CXCL13 and hepatocellular carcinoma: Dysregulated CXCL13 expression is seen in solid tumors including colorectal [35], breast [36], prostate [37], lung [38], and hepatocellular cancer [39] as well as lymphatic hematological malignancies like lymphoma [40] and CLL [20].